Fundacion Seimc-gesida
Clinical trials sponsored by Fundacion Seimc-gesida, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- A crystal ball for ICU infections? new model aims to forecast who survives resistant bacteria Results expected May 2027 (estimated)
-
Can a Two-Drug HIV pill hold the line when resistance lurks?
Disease control CompletedResearchers are testing whether a daily pill combining dolutegravir and lamivudine keeps HIV suppressed in adults whose virus is already under control but who have a history of resistance to lamivudine. The study enrolls 167 participants who switch from their current HIV treatmen…
Phase 2 • Sponsor: Fundacion SEIMC-GESIDA • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Mobile clinic brings HIV treatment to the streets: Same-Day start could transform care for the excluded
Disease control CompletedThis study tests a new way to help vulnerable people with HIV get diagnosed and start treatment right away using a mobile screening unit. Participants receive the once-daily pill Biktarvy on the same day they are enrolled. The goal is to see if this approach helps them stay in ca…
Phase 4 • Sponsor: Fundacion SEIMC-GESIDA • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC